NCT05592483 2024-11-07
DB RESPOND
AstraZeneca
Terminated
Clinical Trials
3 trialsNCT06126003 2024-08-02
Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.
BioCorteX Inc
Terminated
NCT00002668 2023-06-22
Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer
Eastern Cooperative Oncology Group
Phase NA Terminated